Author:
Bjørge L,Hakulinen J,Vintermyr O K,Jarva H,Jensen T S,Iversen O E,Meri S
Publisher
Springer Science and Business Media LLC
Reference53 articles.
1. Abendstein B, Marth C, Muller-Holzner E, Widschwendter M, Daxenbichler G, Zeimet AG (2000) Clinical significance of serum and ascitic p53 autoantibodies in epithelial ovarian carcinoma. Cancer 88: 1432–1437
2. Alexandrakis MG, Kyriakou D, Koutroubakis IE, Alexandraki R, Vlachonikolis IG, Eliopoulos GD (2001) Assaying of tumour necrosis factor alpha, complement factors, and alpha-1-antitrypsin in the diagnosis of malignant serous effusions. Am J Clin Oncol 24: 562–565
3. Baekelandt MM, Holm R, Nesland JM, Trope CG, Kristensen GB (2000) P-glycoprotein expression is a marker for chemotherapy resistance and prognosis in advanced ovarian cancer. Anticancer Res 20: 1061–1067
4. Bjørge L, Hakulinen J, Wahlstrom T, Matre R, Meri S (1997a) Complement-regulatory proteins in ovarian malignancies. Int J Cancer 70: 14–25
5. Bjørge L, Jensen TS, Matre R (1996) Characterisation of the complement-regulatory proteins decay-accelerating factor (DAF, CD55) and membrane cofactor protein (MCP, CD46) on a human colonic adenocarcinoma cell line. Cancer Immunol Immunother 42: 185–192
Cited by
108 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献